rs208290
This is a intron variant variant in the P2RX7 gene.
▶GWAS Catalog Trait Associations (1)
Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.
GWAS Catalog Trait Associations (1)
Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.
level of 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3 in blood, level of 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5 in blood
▶Research that mentions this SNP (1)
▶Genome-wide association study in a Chinese population identifies a susceptibility locus for type 2 diabetes at 7q32 near PAX4Meta-analysisN=41,996Ma RC et al.(2013)· Diabetologia
A genome-wide association study meta-analysis of 684 type 2 diabetes cases and 955 controls in Southern Han Chinese identified rs10229583 at 7q32 near PAX4 as a novel susceptibility locus. The risk allele (G) showed genome-wide significance in a combined analysis of 11,067 cases and 7,929 controls (p=2.6×10⁻⁸; OR [95% CI] 1.18 [1.11, 1.25]) and was consistently associated across East Asian populations (p=2.3×10⁻¹⁰; OR 1.14 [1.09, 1.19]) with evidence of replication in European descent populations (p=8.6×10⁻³). The variant was associated with elevated fasting plasma glucose, impaired beta cell function, and earlier age at diabetes diagnosis.
About P2RX7
The product of this gene belongs to the family of purinoceptors for ATP. This receptor functions as a ligand-gated ion channel and is responsible for ATP-dependent lysis of macrophages through the formation of membrane pores permeable to large molecules. Activation of this nuclear receptor by ATP in the cytoplasm may be a mechanism by which cellular activity can be coupled to changes in gene expression. Multiple alternatively spliced variants have been identified, most of which fit nonsense-mediated decay (NMD) criteria. [provided by RefSeq, Jul 2010]
View all P2RX7 variants →Gene information from NCBI Gene. Variant classifications from ClinVar.
Community Wiki
No community notes yet for this variant. Sign in to start one.
Comments
Sign in to join the discussion.
Loading comments…